Read articles from Global

January 23, 2025 by medscape.com

The FDA proposed limiting nicotine in cigarettes and some tobacco products to reduce addiction. The rule targets combustible products and aims to lower nicotine to 0.7 mg/g of tobacco from the current 6-12 mg in cigarettes. E-cigarettes and nicotine pouches are not affected. The FDA predicts the measure could prevent millions of youth from starting smoking and save lives. Anti-tobacco groups support the proposal, emphasizing its potential to reduce diseases and deaths caused by tobacco use. The FDA's proposal is open for public comment until September 15 and excludes certain tobacco products.

January 23, 2025 by ucl.ac.uk

A UCL study funded by Cancer Research UK reveals an increase in dual users both smoking and vaping in England, particularly among young adults. Data from 2016 to 2024 shows a rise from 3.5% to 5.2%, with more frequent vaping replacing smoking among dual users. Accurate messaging on smoking and vaping harms is crucial for informed decisions, as daily vaping aids smoking cessation. The study emphasizes the need for sustained funding for smoking cessation services to combat tobacco-related cancers. Vaping is recommended for smokers to quit, with caution for non-smokers. Efforts to inform and regulate vaping are essential for public health.

January 22, 2025 by whyy.org

Nicotine pouches, like the Zyn brand, are gaining traction in the U.S. market as a smokeless alternative to traditional tobacco products. Recently, the U.S. Food and Drug Administration (FDA) authorized Zyn as a less harmful option compared to cigarettes and other smokeless tobacco products. While researchers see potential for harm reduction among smokers, they emphasize the need for stricter marketing oversight to prevent youth usage. Currently, nicotine pouch use among teens is low, with fewer than 2% of middle and high school students reporting use in the past year, according to the 2024 National Youth Tobacco Survey.

January 22, 2025 by daily-pouch.com

Startups need product-market fit, solving real problems. Anti-nicotine apps like Jones, despite good marketing, face challenges. They focus on quitting vaping and pouches, which cater to a small market. Investors' $5 million bet on Jones may struggle due to the shrinking vaping trend. Critically, these apps may not address significant issues, unlike stop smoking apps. While hoping for their success, the effectiveness and ethical concerns of anti-nicotine apps remain questionable, as they target a less urgent problem compared to smoking cessation.

January 22, 2025 by medicalxpress.com

To understand factors that led to the escalation, researchers at the University of Alabama at Birmingham studied how college students perceived the health risks of e-cigarettes compared to traditional cigarettes. The results showed the perception of the potential harm of e-cigarettes varied based on factors like sex, vaping status, and field of study/work. "We found that non-users and females were less likely to believe that e-cigarettes were less harmful than traditional cigarettes," said M.J. Ruzmyn Vilcassim, Ph.D., assistant professor in the UAB School of Public Health and lead author. "Conversely, male vapers and users of pod-type devices were more likely to view the devices as less harmful."

January 21, 2025 by thefirebreak.org

In 2018, discussions were held on reforming the International Agency for Research on Cancer (IARC) within the WHO. Suggestions to stay in and reform IARC were made based on concerns regarding activist influences and collaborations with US tort lawyers. The US government intervened in IARC decisions, delaying publications and influencing reports. Despite criticisms of the WHO and its political agenda, leaving the organization may lead to limited influence in global health decisions, especially in combating industry relations. The decision to exit the WHO, made by the US in 2020, may result in diminished influence over global health policies and WHO's strategies, including denormalizing industry relations.

January 21, 2025 by jamanetwork.com

This survey study including 25 094 smokers aged at least 16 years found that e-cigarettes were both the most commonly used cessation aid (used in 40.2% of quit attempts in 2023-2024) and associated with the highest odds of successful cessation. By contrast, other aids found to be associated with increased odds of success in quitting smoking were used in less than 5% of quit attempts.

January 20, 2025 by clivebates.com

Fixing the broken tobacco and nicotine market requires a radical overhaul of the authorisation process for smoke-free products, lowering barriers to entry and pushing back a giant illicit market. This report provides analysis and a framework to support the reform of federal tobacco and nicotine market regulation, one of the most chaotic and conspicuous failures of the federal government and Food and Drug Administration.

January 20, 2025 by thesun.co.uk

System could not access the page, the text article must be completed manually

January 17, 2025 by gfn.tv

Public perceptions of nicotine have long been marred by its association with harmful constituents of tobacco smoke, despite the substantial evidence showing that nicotine is not responsible for the many non-communicable diseases caused by tobacco smoking. Nicotine, safely administered, has long been accepted by governments and health authorities, including the WHO, as a valuable tool to aid smoking cessation in the form of nicotine replacement therapy. Joining us today is Michael Kariuki, a consultant pediatrician and epidemiologist from Kenya, to discuss the therapeutic applications of nicotine and the vital role of safer nicotine products in aiding smoking cessation.